Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-28

Clinical Trial Update: GF-GS 01: Comparing Conventional Axillary Dissection Versus Sentinel Node Resection in Clinically Node-negative Operable Breast Cancer [Phase 3]

View source ↗

Summary

A phase 3 trial comparing conventional axillary dissection to sentinel node resection in clinically node-negative operable breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED